Alan Oscroft | Friday, 14th October, 2016
Biotechnology is big business, but can you spot tomorrow's winners? More »
Should you buy Neil Woodford’s favourite small caps Purplebricks Group plc, 4d Pharma plc and Imperial Innovations Group plc?
Ian Pierce | Wednesday, 22nd June, 2016
What does the future hold for Purplebricks Group plc (LON: PURP), 4D Pharma plc (LON: DDDD) and Imperial Innovations Group plc (LON: IVO)? More »
Why is Neil Woodford so bullish on drugmakers GlaxoSmithKline plc, AstraZeneca plc and 4D Pharma plc?
Ian Pierce | Wednesday, 18th May, 2016
Will GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and 4D Pharma plc (LON: DDDD) be the cure for poor returns? More »
Neil Woodford Buys More ‘Profoundly Undervalued’ Allied Minds PLC, 4d Pharma PLC And Midatech Pharma PLC
G A Chester | Friday, 18th March, 2016
Ace fund manager Neil Woodford sees huge value in Allied Minds PLC (LON:ALM), 4d Pharma PLC (LON:DDDD) and Midatech Pharma PLC (LON:MTPH). More »
Is It Too Late To Buy 2015 Winners Tiziana Life Sciences PLC (+348%), 4d Pharma PLC (+143%) And Pure Wafer plc (+213%)?
Alan Oscroft | Thursday, 12th November, 2015
Tiziana Life Sciences PLC (LON: TILS), 4d Pharma PLC (LON: DDDD) and Pure Wafer plc (LON: PUR) are storming ahead! More »
The Motley Fool Staff | Tuesday, 2nd September, 2014
4d Pharma PLC (LON:DDDD) says two products will begin clinical studies in the second quarter of 2015. More »